143 related articles for article (PubMed ID: 31317658)
1. Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH.
Moore GW; Van Cott EM; Cutler JA; Mitchell MJ; Adcock DM;
J Thromb Haemost; 2019 Sep; 17(9):1555-1561. PubMed ID: 31317658
[No Abstract] [Full Text] [Related]
2. A 2-year retrospective analysis of laboratory testing for activated protein C resistance with a factor V-corrected activated partial thromboplastin time-based method.
De Bel AV; Van der Cruyssen GA; Devreese KM
Blood Coagul Fibrinolysis; 2006 Mar; 17(2):155-60. PubMed ID: 16479199
[TBL] [Abstract][Full Text] [Related]
3. Effects of storage and thawing conditions on coagulation testing.
Gosselin RC; Honeychurch K; Kang HJ; Dwyre DM
Int J Lab Hematol; 2015 Aug; 37(4):551-9. PubMed ID: 25766006
[TBL] [Abstract][Full Text] [Related]
4. Comparison between two functional assays to detect factor V Leiden.
Gessoni G; Valverde S; Manoni F
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e188-9. PubMed ID: 19228222
[No Abstract] [Full Text] [Related]
5. The dilute Russell's viper venom time.
Radhakrishnan K
Methods Mol Biol; 2013; 992():341-8. PubMed ID: 23546726
[TBL] [Abstract][Full Text] [Related]
6. A new dilution for the modified APTT-based assay for activated protein C resistance: improvement of the reliability in patients with a lupus anticoagulant.
Benattar N; Schved JF; Biron-Andréani C
Thromb Haemost; 2000 Jun; 83(6):967-8. PubMed ID: 10896260
[No Abstract] [Full Text] [Related]
7. Prothrombin time and partial thromboplastin time assay considerations.
Ng VL
Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C resistance and lupus anticoagulant in pregnancy.
Busowski JD; Jenkins AD; Hale EU; Busowski M; Dacus JV
J Matern Fetal Med; 1999; 8(6):298-9. PubMed ID: 10582865
[TBL] [Abstract][Full Text] [Related]
9. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
d'Audigier C; Delassasseigne C; Robert A; Eschwège V
Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
[TBL] [Abstract][Full Text] [Related]
10. Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH.
Tripodi A; de Laat B; Wahl D; Ageno W; Cosmi B; Crowther M;
J Thromb Haemost; 2016 Nov; 14(11):2304-2307. PubMed ID: 27860336
[No Abstract] [Full Text] [Related]
11. Dishomogeneous separation of citrated plasma in primary collection tubes for routine coagulation testing.
Lippi G; Salvagno GL; Bassi A; Montagnana M; Poli G; Guidi GC
Blood Coagul Fibrinolysis; 2008 Jun; 19(4):330-2. PubMed ID: 18469561
[No Abstract] [Full Text] [Related]
12. The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance.
Chitolie A; Lawrie AS; Mackie IJ; Harrison P; Machin SJ
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):179-86. PubMed ID: 11414631
[TBL] [Abstract][Full Text] [Related]
13. Sample rerun after short-term refrigerated storage: impact on routine coagulation testing.
Da Rin G; Lippi G
Int J Lab Hematol; 2014 Oct; 36(5):e71-3. PubMed ID: 24382128
[No Abstract] [Full Text] [Related]
14. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
Pengo V; Tripodi A; Reber G; Rand JH; Ortel TL; Galli M; De Groot PG;
J Thromb Haemost; 2009 Oct; 7(10):1737-40. PubMed ID: 19624461
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
16. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
Ivey LM; Thom JY; Ivey JG; Baker RI
Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
[TBL] [Abstract][Full Text] [Related]
17. Factor V Leiden.
Van Cott EM; Khor B; Zehnder JL
Am J Hematol; 2016 Jan; 91(1):46-9. PubMed ID: 26492443
[TBL] [Abstract][Full Text] [Related]
18. Multilaboratory testing of thrombophilia: current and past practice in Australasia as assessed through the Royal College of Pathologists of Australasia Quality Assurance Program for Hematology.
Favaloro EJ; Bonar R; Sioufi J; Wheeler M; Low J; Aboud M; Duncan E; Smith J; Exner T; Lloyd J; Marsden K;
Semin Thromb Hemost; 2005 Feb; 31(1):49-58. PubMed ID: 15706475
[TBL] [Abstract][Full Text] [Related]
19. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
20. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
